drugset / Trial / NCT00006095

Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy

NCT00006095

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of vincristine plus irinotecan in treating children who have solid tumors that have not responded to previous therapy.

Timeline

Start
2000-07
Primary completion
2005-01
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule Intravenous
Subject Vincristine Small molecule 1.5 mg/m2 Intravenous
Subject Vincristine Small molecule 2 mg/m2 Intravenous